A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: A study of the PMH phase II consortium

Natasha B. Leighl, Scott A. Laurie, Xueyu E. Chen, Peter Ellis, Frances A. Shepherd, Jennifer J. Knox, Glenwood Goss, Ronald L. Burkes, Gregory R. Pond, Christopher Dick, Yun Yen, James A. Zwiebel, Malcolm J. Moore

研究成果: 雜誌貢獻 › 文章 › 同行評審